Cyntegrity Launches Centralized Monitoring for COVID-19 Affected Studies


Applied Clinical Trials

With recent FDA Guidance on Clinical Trials COVID-19 suggesting, “If planned on-site monitoring visits are no longer possible, sponsors should consider optimizing the use of central and remote monitoring programs to maintain oversight of clinical sites," Risk-Based Quality Management (RBQM) solutions provider Cyntegrity is offering its special COVID-19 rapid deployment pack on a non-profit basis at cost on a month-to-month basis for a flat rate with no per-seat or per-site charge.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.